Home
>
National Drug Code (NDC)
>
Atracurium Besylate
Atracurium Besylate - 55390-103-10 - (Atracurium Besylate)
Drug Information of Atracurium Besylate
| Product NDC: | 55390-103 |
| Proprietary Name: | Atracurium Besylate |
| Non Proprietary Name: | Atracurium Besylate |
| Active Ingredient(s): | 10 mg/mL & nbsp; Atracurium Besylate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Atracurium Besylate
| Product NDC: | 55390-103 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074901 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970915 |
Package Information of Atracurium Besylate
| Package NDC: | 55390-103-10 |
| Package Description: | 10 VIAL in 1 BOX (55390-103-10) > 10 mL in 1 VIAL |
NDC Information of Atracurium Besylate
| NDC Code | 55390-103-10 |
| Proprietary Name | Atracurium Besylate |
| Package Description | 10 VIAL in 1 BOX (55390-103-10) > 10 mL in 1 VIAL |
| Product NDC | 55390-103 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Atracurium Besylate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19970915 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | ATRACURIUM BESYLATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
